| Stage | IQV | % of rev | NRC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $4.4B | 100.00% | $38M | 100.00% | IQV ×115.32 |
| Gross profit | $1.5B | 33.83% | $38M | 100.00% | NRC +66.2pp |
| Operating income | $572M | 12.92% | $9M | 23.20% | NRC +10.3pp |
| Pre-tax income | $386M | 8.72% | $7M | 19.28% | NRC +10.6pp |
| Net income | $352M | 7.95% | $5M | 12.25% | NRC +4.3pp |
| Stage | IQV | NRC | Gap · A − B |
|---|---|---|---|
| Revenue | $4.4B100.00% | $38M100.00% | IQV ×115.32 |
| Gross profit | 33.83%$1.5B | 100.00%$38M | NRC +66.2pp |
| Operating income | 12.92%$572M | 23.20%$9M | NRC +10.3pp |
| Pre-tax income | 8.72%$386M | 19.28%$7M | NRC +10.6pp |
| Net income |
| 7.95%$352M |
| 12.25%$5M |
| NRC +4.3pp |